Document is current
Any future updates will be listed below
-
Authors
Bochenek, Matthew A.
Veiseh, Omid
Vegas, Arturo J.
McGarrigle, James J.
Qi, Meirigeng
Marchese, Enza
Omami, Mustafa
Doloff, Joshua C.
Mendoza-Elias, Joshua
Nourmohammadzadeh, Mohammad
Khan, Arshad
Yeh, Chun-Chieh
Xing, Yuan
Isa, Douglas
Ghani, Sofia
Li, Jie
Landry, Casey
Bader, Andrew R.
Olejnik, Karsten
Chen, Michael
Hollister-Lock, Jennifer
Wang, Yong
Greiner, Dale L.
Weir, Gordon C.
Strand, Berit Løkensgard
Rokstad, Anne Mari A.
Lacik, Igor https://orcid.org/0000-0001-6037-3747
Langer, Robert
Anderson, Daniel G.
Oberholzer, Jose
- License Information
-
More Information
Article History
Received: 26 October 2017
Accepted: 12 July 2018
First Online: 13 August 2018
Competing interests
: O.V., A.J.V., R.L., D.G.A. and J.O. are founding scientists of Sigilon Therapeutics, a biotech company based in Cambridge, MA, USA, that produces antifibrotic materials for cell-based therapies. J.O. is founder and President of CellTrans, a biotech company based in Chicago, IL, USA, for the transplantation of cell-based therapies.
